Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary ...

In the first randomized controlled trial of its kind, the drug tadalafil reduced the duration and frequency of secondary Raynaud's phenomenon episodes in patients with scleroderma and mixed ...